Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection
- PMID: 37326146
- DOI: 10.1111/jdv.19261
Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection
References
REFERENCES
-
- Beytout Q, Pepiot J, Maruani A, Devulder D, Aubert R, Beylot-Barry M, et al. Impact of the COVID-19 pandemic on children with psoriasis. Ann Dermatol Venereol. 2021;148:106-11.
-
- Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, et al. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. J Allergy Clin Immunol. 2021;147:60-71.
-
- Zitouni J, Bursztejn AC, Belloni Fortina A, Beauchet A, di Lernia V, Lesiak A, et al. Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry). J Eur Acad Dermatol Venereol. 2022;36:2076-86.
-
- Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, et al. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol. 2019;60:91-8.
-
- Yoneda K, Matsuoka-Shirahige Y, Demitsu T, Kubota Y. Pustular psoriasis precipitated by cytomegalovirus infection. Br J Dermatol. 2012;167:1186-9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous